A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2002
11/28/2002	US20020177772 Drug delivery catheters that attach to tissue and methods for their use
11/28/2002	US20020177626 Comprises analgesics such as ibuprofen and diphenhydramine; storage stability
11/28/2002	US20020177625 Class of glaucoma drugs to enhance aqueous humor outflow and lower intra-ocular pressure
11/28/2002	US20020177624 Prevents vaginitis
11/28/2002	US20020177621 Comprises aliphatic/aromatic alcohol and aliphatic/aromatic aldehyde; synergism; for use in room, closet or shoe box
11/28/2002	US20020177620 Prostanoic acid derivatives as agents for lowering intraocular pressure
11/28/2002	US20020177615 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
11/28/2002	US20020177602 Antidiabetic formulation and method
11/28/2002	US20020177582 For diagnosing and treating urogenital disorders associated with atrophic vaginitis in symptomatic women having vaginal pH of 4.5 or above
11/28/2002	US20020177581 Novel anti-inflammatory androstane derivative
11/28/2002	US20020177579 Extended release formulation of water-soluble drugs
11/28/2002	US20020177577 Contact lens preservative solution
11/28/2002	US20020177576 Nucleotide compounds that block the bitter taste of oral compositions
11/28/2002	US20020177574 Endometrial gene therapy
11/28/2002	US20020177562 Dissolving in an acidified solvent and spray-drying to form a powder suitable for oral inhalation to the lung
11/28/2002	US20020177534 Liquid foaming soap compositions and dispensing system therefor
11/28/2002	US20020177522 Solid media
11/28/2002	US20020177226 Pharmaceutical dipeptide compositions and methods of use thereof: immunostimulants
11/28/2002	US20020177118 Monochromatic fluid treatment systems
11/28/2002	US20020176987 Ink comprising: a non-stoichiometric non-equilibrium nanostructured material; device such as electronics using such a material
11/28/2002	US20020176935 Microprecipitation method for preparing submicron suspensions
11/28/2002	US20020176926 Method and apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
11/28/2002	US20020176911 Includes xanthan gum which improves tolerance (e.g. less gastrointestinal symptoms such as emesis, stool patterns and gas)
11/28/2002	US20020176898 Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
11/28/2002	US20020176897 Treating cancer cells that express a membrane protein tNOX, a hormone-insensitive and drug-responsive form of NOX (NADH oxidase) specific to cancer cells
11/28/2002	US20020176894 For an azole antifungal or antibacterial drug; core and a drug emulsion layer containing the drug, an emulsifier, binder and absorbent aid such as citric acid; solubility, bioavailability
11/28/2002	US20020176893 Applying a mixture of a water insoluble particle and a carrier; promotes inflammatory response; for closing of the vas deferens, lessening menstrual flow, repairing intervertebral disc rupture
11/28/2002	US20020176892 Sterile gelled composition of a matrix containing an anionic "polymer" such as chondroitin sulfate blended with a nonionic polymer such as hydroxyethyl cellulose in given ratio; topically applying for pain relief from e.g. arthritis
11/28/2002	US20020176891 Topical gel delivery system
11/28/2002	US20020176890 Gellan gum tablet coating
11/28/2002	US20020176889 And an excipient wherein the pH is within the range of 5.5-7.0; stability; dosage forms
11/28/2002	US20020176888 Oral dosage forms
11/28/2002	US20020176887 Methods of delivery of cetyl myristoleate
11/28/2002	US20020176886 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
11/28/2002	US20020176885 Given concentration of halide-comprising salts such as sodium chloride; nonirritating antiseptic; can be used in eyes
11/28/2002	US20020176880 A polymeric hydrogel material that permits cellular ingrowth and has controlled rate of expansion optimized for delivery through microcatheter or catheter without need for a nonaqueous solvent or coating
11/28/2002	US20020176849 Endomural therapy
11/28/2002	US20020176846 Storage stable powder compositions of interleukin-4 receptor
11/28/2002	US20020176842 A dosage form comprising an ionizable active ingredient and an unloaded ion exchange resin, coated with a permeable membrane; drug release and absorption depending on the conditions under which the membrane dissolves
11/28/2002	US20020176841 Pharmaceutical formulations for sustained release
11/28/2002	US20020176840 A porous spherical carbonaceous substance has a diameter 0.01 to 1 mm, and a specific surface area, excellent adsorbability of harmful toxins in gastrointestinal tracts; treating patients with liver or renal diseases
11/28/2002	US20020176835 Crosslinked water-soluble or water-swellable copolymers based on acrylamidoalkylsulfonic acids and cyclic N-vinylcarboxamides
11/28/2002	US20020176832 Cosmetic or dermatological oil-in-water emulsions comprising up to 90% by weight water phase, up to 40% by weight lipid phase, up to 10% by weight polymer
11/28/2002	US20020176828 Remineralizaing-mineralizing oral products containing discrete cationic and anionic agglomerate components and method of use
11/28/2002	US20020176827 Carrier and composition comprising polybutene with molecular weight of 300-3000 and one or more cosmetic or therapeutic actives, releasably associated to carrier
11/28/2002	US20020176825 Aerosols containing annealed particulate salbutamol and tetrafluoroethane
11/28/2002	US20020176824 Medicaments
11/28/2002	US20020175191 Fluid delivery device having a water generating electrochemical/chemical pump and associated method
11/28/2002	DE10141650C1 Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate
11/28/2002	CA2641760A1 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
11/28/2002	CA2454551A1 Controlled release drug delivery device
11/28/2002	CA2449202A1 Biocompatible compositions as carriers or excipients for pharmaceutical and nutraceutical formulations and for food protection
11/28/2002	CA2448449A1 Treatment of renal fibrosis
11/28/2002	CA2448031A1 Method for stabilising of nucleic acids
11/28/2002	CA2448022A1 Compositions for protein delivery via the pulmonary route
11/28/2002	CA2447793A1 Immunostimulatory oligodeoxynucleic molecules
11/28/2002	CA2447619A1 A composition for accelerating bone fracture healing
11/28/2002	CA2447618A1 A composition for regenerative treatment of cartilage disease
11/28/2002	CA2447603A1 Granular preparations of gaboxadol
11/28/2002	CA2447600A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
11/28/2002	CA2447236A1 Pulmonary administration of chemically modified insulin
11/28/2002	CA2447170A1 Emulsion and dispersion formulations and method
11/28/2002	CA2447135A1 Fluid delivery device having a water generating electrochemical/chemical pump and associated method
11/28/2002	CA2445789A1 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
11/28/2002	CA2443068A1 Veterinary compositions comprising avermectin-oxime derivatives and praziquantel
11/28/2002	CA2441801A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	CA2427381A1 Transdermal drug delivery devices having coated microprotrusions
11/28/2002	CA2349123A1 Anionic exchange polymer complexes of buspirone
11/27/2002	EP1260534A2 Blends of absorbable polyoxaesters
11/27/2002	EP1260244A2 Osmotic drug delivery monitoring system and method
11/27/2002	EP1260233A1 P-glycoprotein modifier-containing medicinal compositions to be delivered to the large intestine
11/27/2002	EP1260230A1 Preparations stabilized over long time
11/27/2002	EP1260225A1 A pharmaceutical composition for use in hormone replacement therapy
11/27/2002	EP1260220A1 Bubbling tablet, bubbling bath additive tablet, bubbling washing detergent tablet, bubbling tablet for oral administration, and processes for producing these
11/27/2002	EP1260219A2 Dip coating compositions containing cellulose ethers
11/27/2002	EP1260218A2 Dip coating compositions containing starch or dextrin
11/27/2002	EP1260217A2 Simethicone as weight gain enhancer for coating compositions
11/27/2002	EP1260216A1 Multi-layered pharmaceutical composition for both intraoral and oral administration
11/27/2002	EP1260215A1 Rapidly disintegrable tablet containing polyvinyl alcohol
11/27/2002	EP1260213A2 Form of administration of immunologically active ingredients
11/27/2002	EP1259808A2 Method for labeling individual cells
11/27/2002	EP1259592A1 Monocyte-derived dendritic cell subsets
11/27/2002	EP1259530A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/27/2002	EP1259513A2 A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR
11/27/2002	EP1259493A2 Substituted piperazine compounds
11/27/2002	EP1259470A2 A group of anti-cancer compounds with specific structure and their production method
11/27/2002	EP1259429A2 Metered dose inhaler
11/27/2002	EP1259277A1 Metered dose inhaler
11/27/2002	EP1259276A2 Metered dose inhaler
11/27/2002	EP1259262A1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
11/27/2002	EP1259261A1 Pharmaceutical compositions comprising terbinafine
11/27/2002	EP1259259A2 Mucosal adjuvant formulation
11/27/2002	EP1259250A1 Endoparasiticidal agents
11/27/2002	EP1259244A1 Veterinary compositions for the treatment of parasitic diseases
11/27/2002	EP1259243A2 Bupropion metabolites and methods of their synthesis and use
11/27/2002	EP1259238A1 Stable acid labile benzimidazole pharmaceutical compositions
11/27/2002	EP1259230A2 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure
11/27/2002	EP1259228A1 Therapeutic compositions for pulmonary delivery
11/27/2002	EP1259227A1 Method for producing pharmaceutical dosage forms
11/27/2002	EP1259226A2 Anaesthetic formulations

1 ... 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 ... 2991